BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33633408)

  • 21. Innate resistance to flavivirus infections and the functions of 2'-5' oligoadenylate synthetases.
    Mashimo T; Simon-Chazottes D; Guénet JL
    Curr Top Microbiol Immunol; 2008; 321():85-100. PubMed ID: 18727488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.
    Hernández Cordero AI; Li X; Milne S; Yang CX; Bossé Y; Joubert P; Timens W; van den Berge M; Nickle D; Hao K; Sin DD
    Hum Genet; 2021 Jun; 140(6):969-979. PubMed ID: 33604698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endomembrane targeting of human OAS1 p46 augments antiviral activity.
    Soveg FW; Schwerk J; Gokhale NS; Cerosaletti K; Smith JR; Pairo-Castineira E; Kell AM; Forero A; Zaver SA; Esser-Nobis K; Roby JA; Hsiang TY; Ozarkar S; Clingan JM; McAnarney ET; Stone AE; Malhotra U; Speake C; Perez J; Balu C; Allenspach EJ; Hyde JL; Menachery VD; Sarkar SN; Woodward JJ; Stetson DB; Baillie JK; Buckner JH; Gale M; Savan R
    Elife; 2021 Aug; 10():. PubMed ID: 34342578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrasted patterns of variation and evolutionary convergence at the antiviral OAS1 gene in old world primates.
    Fish I; Boissinot S
    Immunogenetics; 2015 Sep; 67(9):487-99. PubMed ID: 26156123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies.
    Luo S; Liang Y; Wong THT; Schooling CM; Au Yeung SL
    Int J Epidemiol; 2022 Aug; 51(4):1088-1105. PubMed ID: 35445260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses.
    Rios JJ; Fleming JG; Bryant UK; Carter CN; Huber JC; Long MT; Spencer TE; Adelson DL
    PLoS One; 2010 May; 5(5):e10537. PubMed ID: 20479874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.
    Kjær KH; Pahus J; Hansen MF; Poulsen JB; Christensen EI; Justesen J; Martensen PM
    BMC Cell Biol; 2014 Sep; 15():33. PubMed ID: 25205466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study.
    Butler-Laporte G; Nakanishi T; Mooser V; Renieri A; Amitrano S; Zhou S; Chen Y; Forgetta V; Richards JB
    Int J Epidemiol; 2021 Mar; 50(1):75-86. PubMed ID: 33349849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module.
    Lee HK; Knabl L; Knabl L; Wieser M; Mur A; Zabernigg A; Schumacher J; Kapferer S; Kaiser N; Furth PA; Hennighausen L
    Sci Rep; 2022 Feb; 12(1):2784. PubMed ID: 35181735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
    Gaziano L; Giambartolomei C; Pereira AC; Gaulton A; Posner DC; Swanson SA; Ho YL; Iyengar SK; Kosik NM; Vujkovic M; Gagnon DR; Bento AP; Barrio-Hernandez I; Rönnblom L; Hagberg N; Lundtoft C; Langenberg C; Pietzner M; Valentine D; Gustincich S; Tartaglia GG; Allara E; Surendran P; Burgess S; Zhao JH; Peters JE; Prins BP; Angelantonio ED; Devineni P; Shi Y; Lynch KE; DuVall SL; Garcon H; Thomann LO; Zhou JJ; Gorman BR; Huffman JE; O'Donnell CJ; Tsao PS; Beckham JC; Pyarajan S; Muralidhar S; Huang GD; Ramoni R; Beltrao P; Danesh J; Hung AM; Chang KM; Sun YV; Joseph J; Leach AR; Edwards TL; Cho K; Gaziano JM; Butterworth AS; Casas JP;
    Nat Med; 2021 Apr; 27(4):668-676. PubMed ID: 33837377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancer.
    Mandal S; Abebe F; Chaudhary J
    Cancer; 2011 Dec; 117(24):5509-18. PubMed ID: 21638280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
    Leong A; Cole JB; Brenner LN; Meigs JB; Florez JC; Mercader JM
    PLoS Med; 2021 Mar; 18(3):e1003553. PubMed ID: 33661905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis.
    Zhao Y; Kang H; Ji Y; Chen X
    Clin Exp Med; 2013 Aug; 13(3):171-6. PubMed ID: 22710942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor.
    Danziger O; Patel RS; DeGrace EJ; Rosen MR; Rosenberg BR
    PLoS Pathog; 2022 Apr; 18(4):e1010464. PubMed ID: 35421191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 and Thyroid Function: A Bi-Directional Two-Sample Mendelian Randomization Study.
    Li GH; Tang CM; Cheung CL
    Thyroid; 2022 Sep; 32(9):1037-1050. PubMed ID: 35734897
    [No Abstract]   [Full Text] [Related]  

  • 36. [A case-control study on association between OAS1 polymorphism and susceptibility to spontaneous preterm birth and preterm premature rupture of membranes].
    Yang X; Zhang XA; Wu ZH; Peng W; Zhu LN; Wang Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):898-902. PubMed ID: 26412166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [
    Yaping LI; Song Z; Wenjun W; Huiling D; Mei LI; Xiaoli J; Shuangsuo D
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Apr; 39(4):381-386. PubMed ID: 31068279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2'-5'-Oligoadenylate synthetase 1 polymorphisms are associated with tuberculosis: a case-control study.
    Wu S; Wang Y; Chen G; Zhang M; Wang M; He JQ
    BMC Pulm Med; 2018 Nov; 18(1):180. PubMed ID: 30497421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the 5' untranslated region in SARS-CoV-2 genome and its specific recognition by innate immune system
    Bignon E; Miclot T; Terenzi A; Barone G; Monari A
    Chem Commun (Camb); 2022 Feb; 58(13):2176-2179. PubMed ID: 35060977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
    Huang W; Xiao J; Ji J; Chen L
    Elife; 2021 Dec; 10():. PubMed ID: 34866576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.